No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Ming-Chung Kuo; Tsai-Yun Chen; Ming-Chung Wang; Youngsen Yang; Su-Peng Yeh; Cheng-Shyong Chang; Yii-Jenq Lan; Chih-cheng Chen; Yu-Chieh Su; Pei-Ching Hsiao; Ching-Yuan Kuo; Li-Yuan Bai; Wen-Li Hwang; Lee-Yung Shih

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Ming-Chung Kuo, Tsai-Yun Chen, Ming-Chung Wang, Youngsen Yang, Su-Peng Yeh, Cheng-Shyong Chang, Yii-Jenq Lan, Chih-cheng Chen, Yu-Chieh Su, Pei-Ching Hsiao, Ching-Yuan Kuo, Li-Yuan Bai, Wen-Li Hwang, Lee-Yung Shih

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Blood
Volume	124
Issue number	21
State	Published - 2014

Cite this

Kuo, M.-C., Chen, T.-Y., Wang, M.-C., Yang, Y., Yeh, S.-P., Chang, C.-S., Lan, Y.-J., Chen, C., Su, Y.-C., Hsiao, P.-C., Kuo, C.-Y., Bai, L.-Y., Hwang, W.-L., & Shih, L.-Y. (2014). No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study. Blood, 124(21).

@article{35e6e6da0a124df6947ec7a5ae5283e5,

title = "No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study",

author = "Ming-Chung Kuo and Tsai-Yun Chen and Ming-Chung Wang and Youngsen Yang and Su-Peng Yeh and Cheng-Shyong Chang and Yii-Jenq Lan and Chih-cheng Chen and Yu-Chieh Su and Pei-Ching Hsiao and Ching-Yuan Kuo and Li-Yuan Bai and Wen-Li Hwang and Lee-Yung Shih",

year = "2014",

language = "American English",

volume = "124",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "21",

}

Kuo, M-C, Chen, T-Y, Wang, M-C, Yang, Y, Yeh, S-P, Chang, C-S, Lan, Y-J, Chen, C, Su, Y-C, Hsiao, P-C, Kuo, C-Y, Bai, L-Y, Hwang, W-L & Shih, L-Y 2014, 'No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study', Blood, vol. 124, no. 21.

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study. / Kuo, Ming-Chung; Chen, Tsai-Yun; Wang, Ming-Chung et al.
In: Blood, Vol. 124, No. 21, 2014.

Research output: Contribution to journal › Journal Article › peer-review

TY - JOUR

T1 - No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

AU - Kuo, Ming-Chung

AU - Chen, Tsai-Yun

AU - Wang, Ming-Chung

AU - Yang, Youngsen

AU - Yeh, Su-Peng

AU - Chang, Cheng-Shyong

AU - Lan, Yii-Jenq

AU - Chen, Chih-cheng

AU - Su, Yu-Chieh

AU - Hsiao, Pei-Ching

AU - Kuo, Ching-Yuan

AU - Bai, Li-Yuan

AU - Hwang, Wen-Li

AU - Shih, Lee-Yung

PY - 2014

Y1 - 2014

M3 - Journal Article

SN - 0006-4971

VL - 124

JO - Blood

JF - Blood

IS - 21

ER -